Vaccine prevented 42 lakh Covid deaths in India in 2021: Study

The Lancet Infectious Diseases journal, which based its findings on estimates of “excess” mortalities in the country during the pandemic. 

published on : 25th June 2022

Government panel recommends emergency approval for SII's Covovax for 7-11 year olds

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9.

published on : 24th June 2022

Covid vax prevented over 42 lakh deaths in India: Lancet

Further 599,300 lives could have been saved if the World Health Organization's target of vaccinating 40 per cent of the population in each country with two or more doses by end of 2021 had been met.

published on : 24th June 2022

Kolkata Diary: Confusion over getting booster vaccine dose

An committee member said it has been resolved that four of the five departments would admit candidates by awarding equal weightage to tests and Plus-2 marks.

published on : 24th June 2022

DCGI to review Serum Institute's applications for Covovax use in kids aged 2 to 7 yrs, 7 to 11 yrs 

The expert panel in its last meeting in April had sought more data from SII following its application seeking the emergency use authorization of Covovax for seven to 11 years.

published on : 23rd June 2022

Vaccine-derived polio virus detected in London sewage samples: World Health Organization

The wild version of the virus now exists only in Afghanistan and Pakistan, but a type of vaccine that contains small amounts of weakened but live polio still causes occasional outbreaks elsewhere.

published on : 23rd June 2022

Biological-E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine

India's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age group of 12 to 14 years.

published on : 22nd June 2022

WHO approves Hyderabad firm to make vaccines for Johnson & Johnson

"This is a great progress for Quad Vaccine and the US India Health partnership," said a US Embassy spokesperson.

published on : 22nd June 2022

Girl who lost sight day after taking Covid jab, seeks govt help to study medicine

  A 17-year-old girl who lost eyesight a day after she was administered with Covid vaccine at a Ranipet school sought the government’s help to study medicine.

published on : 22nd June 2022

Covid fear makes a comeback as cases surge in Delhi

Delhi reports 1,797 fresh cases on Friday a 35 per cent jump over previous day’s tally, city now has 4,843 active cases.

published on : 18th June 2022

Only 18 per cent in 18-59 years age group receive 3rd vaccine dose

Despite the surge in Covid-19 cases sparking some concern, Delhi residents have not shown much enthusiasm to get the booster shot.

published on : 18th June 2022

FDA authorizes first COVID-19 vaccine shots for toddlers under age five

The regulatory body has now approved Moderna shots for school-aged children and teens as well.

published on : 17th June 2022

WTO agrees to lift Covid vaccine patents, but is it 'too late' as India believes?

Friday's compromise fell short of their earlier requests that the waiver apply to all countries -- and also cover Covid tests and treatments.

published on : 17th June 2022

Covaxin safe, well-tolerated in 2-18 years age-group, Bharat Biotech cites Lancet study

A press release from the vaccine maker said the study has been accepted and published in Lancet Infectious diseases, peer reviewed high impact factor journal.

published on : 17th June 2022

NTAGI sub panel recommends reducing Covid booster dose gap to six months

The panel members found a lack of uniformity in results upon mixing of jabs for booster shots and stated that no recommendation for it can be made as of now.

published on : 16th June 2022
1 2 3 4 5 6 >